(Q39631376)

13 September 2017

1 reference

title

GnRH agonists and antagonists. Current clinical status (English)

1 reference

13 September 2017

M Filicori

1

1 reference

PubMed ID

3278879

13 September 2017

C Flamigni

series ordinal

2

1 reference

13 September 2017

1 January 1988

1 reference

13 September 2017

1 reference

13 September 2017

35

1 reference

13 September 2017

1

1 reference

13 September 2017

63-82

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198835010-00004

13 September 2017

0 references

cites work

Treatment of breast cancer with gonadotropin-releasing hormone

1 reference

12 December 2020

Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty

1 reference

12 December 2020

Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty

1 reference

12 December 2020

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists

1 reference

12 December 2020

Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH

1 reference

12 December 2020

Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas

1 reference

12 December 2020

Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin

1 reference

12 December 2020

Leuprolide versus diethylstilbestrol for metastatic prostate cancer

1 reference

12 December 2020

Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women

1 reference

12 December 2020

Combined treatment with ketoconazole and luteinising hormone releasing hormone analogue: a novel approach to resistant progressive prostatic cancer

1 reference

12 December 2020

D-TRP5-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty

1 reference

12 December 2020

The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy

1 reference

12 December 2020

Long-acting gonadotropin hormone-releasing hormone analog used to treat uteri

1 reference

12 December 2020

Des lead-in to use of luteinizing hormone releasing hormone analogs in treatment of metastatic carcinoma of prostate

1 reference

12 December 2020

The dynamics of gonadotropin inhibition in women induced by an antagonistic analog of gonadotropin-releasing hormone

1 reference

12 December 2020

Inhibition of pituitary-testicular function with [D-Trp6] luteinizing hormone-releasing hormone in rhesus monkeys.

1 reference

12 December 2020

Response to D-Trp-6-LH-RH in advanced adenocarcinoma of pancreas

1 reference

12 December 2020

Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist

1 reference

12 December 2020

Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone

1 reference

12 December 2020

The premenstrual syndrome. Effects of "medical ovariectomy"

1 reference

12 December 2020

Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome

1 reference

12 December 2020

Failure to induce early abortion by huge doses of a superactive LRH agonist in women

1 reference

12 December 2020

A new systematic treatment for infertile women with abnormal hormone profiles

1 reference

12 December 2020

Combined treatment with buserelin and cyproterone acetate in metastatic prostatic carcinoma

1 reference

12 December 2020

Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins

1 reference

12 December 2020

Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*

1 reference

12 December 2020

Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase

1 reference

12 December 2020

Long-term results of GnRH analogue (Buserelin) treatment in girls with central precocious puberty

1 reference

12 December 2020

Early tumor exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone

1 reference

12 December 2020

Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective

1 reference

12 December 2020

Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women

1 reference

12 December 2020

Luteolytic effect of D-Trp6-luteinizing hormone-releasing hormone in the rhesus monkey (Macaca mulatta)

1 reference

12 December 2020

Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis

1 reference

12 December 2020

Inhibition of ovulation in women by chronic treatment with a stimulatory lrh analogue — A new approach to birth control?

1 reference

12 December 2020

The treatment of central precocious puberty using an intranasal LHRH analogue (buserelin).

1 reference

12 December 2020

Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception

1 reference

12 December 2020

Ac-D-NAL(2)1,4FD-Phe2,D-Trp3,D-Arg6-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats

1 reference

12 December 2020

Administration of luteinizing hormone-releasing hormone analogs delays ovulation without affecting the luteal function in rhesus monkeys

1 reference

12 December 2020

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

1 reference

12 December 2020

Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist

1 reference

12 December 2020

Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin).

1 reference

12 December 2020

Adrenarche and skeletal maturation during luteinizing hormone releasing hormone analogue suppression of gonadarche

1 reference

12 December 2020

Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge

1 reference

12 December 2020

Inhibition of ovulation by intranasal nafarelin, a new superactive agonist of GnRH

1 reference

12 December 2020

Treatment of severe androgen excess due to ovarian hyperthecosis with a long-acting gonadotropin-releasing hormone agonist

1 reference

12 December 2020

True Precocious Puberty Complicating Congenital Adrenal Hyperplasia: Treatment with a Luteinizing Hormone-Releasing Hormone Analog*

1 reference

12 December 2020

Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey

1 reference

12 December 2020

Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist

1 reference

12 December 2020

Luteinising hormone releasing hormone agonist in women with endometriosis.

1 reference

12 December 2020

Effect of gonadotrophin-releasing hormone analogue (GnRH-A) administration on serum gonadotrophin and steroid levels in patients with polycystic ovarian disease.

1 reference

12 December 2020

Sustained suppression of testosterone production by the luteinising-hormone releasing-hormone agonist buserelin in patients with advanced prostate carcinoma. A new therapeutic approach?

1 reference

12 December 2020

Use of a superactive luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia

1 reference

12 December 2020

Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone

1 reference

12 December 2020

Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist: significance of time in cycle

1 reference

12 December 2020

Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins

1 reference

12 December 2020

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

12 December 2020

Intranasal gonadotropin-releasing hormone agonist as a contraceptive agent

1 reference

12 December 2020

Treatment of prostate cancer with gonadotropin-releasing hormone agonists

1 reference

12 December 2020

Treatment of prostatic cancer with a gonadotropin-releasing hormone agonist analog: acute and long term effects on endocrine functions of testis tissue

1 reference

12 December 2020

The treatment of postmenopausal women with advanced breast cancer with buserelin

1 reference

12 December 2020

Steroid secretion in polycystic ovarian disease after ovarian suppression by a long-acting gonadotropin-releasing hormone agonist

1 reference

12 December 2020

Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome

1 reference

12 December 2020

Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive

1 reference

12 December 2020

The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe

1 reference

12 December 2020

Gonadotropin-Independent Familial Sexual Precocity with Premature Leydig and Germinal Cell Maturation (Familial Testotoxicosis): Effects of a Potent Luteinizing Hormone-Releasing Factor Agonist and Medroxyprogesterone Acetate Therapy in Four Cases*

1 reference

12 December 2020

Chorionic gonadotropin prevents LRF-agonist-induced luteolysis in the human

1 reference

12 December 2020

Induction of Luteolysis in the Human with a Long-Acting Analog of Luteinizing Hormone-Releasing Factor

1 reference

12 December 2020

The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat

1 reference

12 December 2020

Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival

1 reference

12 December 2020

Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty

1 reference

12 December 2020

Disease flare induced by D-Trp6-LHRH analogue in patients with metastatic prostatic cancer

1 reference

12 December 2020

Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancer

1 reference

12 December 2020

Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue.

1 reference

12 December 2020

Inhibition of folliculogenesis in the monkey following early follicular phase administration of an LRH agonist

1 reference

12 December 2020

Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen

1 reference

12 December 2020

GnRH and its analogues. Current therapeutic applications and new prospects

1 reference

12 December 2020

Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women

1 reference

12 December 2020

Direct inhibitory effect of a luteinizing hormone-releasing hormone agonist on MCF-7 human breast cancer cells

1 reference

12 December 2020

Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen

1 reference

12 December 2020

D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons

1 reference

12 December 2020

Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men

1 reference

12 December 2020

Hormonal effects of danazol and medical oophorectomy in endometriosis

1 reference

12 December 2020

Bone changes occurring spontaneously and caused by estrogen in early postmenopausal women: a local or generalised phenomenon?

1 reference

12 December 2020

Objective response and disease outcome in 59 patients with stage D2 prostatic cancer treated with either Buserelin or orchiectomy. Disease aggressivity and its association with response and outcome

1 reference

12 December 2020

Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules

1 reference

12 December 2020

Mechanisms of gonadotropin-releasing hormone agonist action in the human male

1 reference

12 December 2020

Long term effects of administration of a gonadotropin-releasing hormone superagonist analog in men with prostatic carcinoma

1 reference

12 December 2020

Clinical effects of gonadotropin-releasing hormone analogue in metastatic carcinoma of prostate

1 reference

12 December 2020

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer

1 reference

12 December 2020

Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease

1 reference

12 December 2020

A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue

1 reference

12 December 2020

Treatment of precocious puberty with LHRH analogue in combination with cyproterone acetate-further experience

1 reference

12 December 2020

Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation

1 reference

12 December 2020

Shrinkage of a uterine fibroid after subcutaneous infusion of a LHRH agonist

1 reference

12 December 2020

Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin)

1 reference

12 December 2020

Heterogeneity of sperm density profiles following 20-week therapy with high-dose LHRH analog plus testosterone

1 reference

12 December 2020

Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma

1 reference

12 December 2020

Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women

1 reference

12 December 2020

Importance of early tumour exacerbation in patients treated with long acting analogues of gonadotrophin releasing hormone for advanced prostatic cancer

1 reference

12 December 2020

Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility

1 reference

12 December 2020

Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.

1 reference

12 December 2020

Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations

1 reference

12 December 2020

Influence of the LH-RH analogue buserelin on cyclic ovarian function and on endometrium. A new approach to fertility control?

1 reference

12 December 2020

Comparison of leuprolide and diethylstilbestrol for stage D2 adenocarcinoma of prostate

1 reference

12 December 2020

Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control

1 reference

12 December 2020

Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion.

1 reference

12 December 2020

Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study

1 reference

12 December 2020

Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report

1 reference

12 December 2020

Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone

1 reference

12 December 2020

LHRH-Agonist treatment in clinical and experimental human breast cancer

1 reference

12 December 2020

"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis

1 reference

12 December 2020

Luteolytic Effect of Intranasal Administration of [D-Ser(TBU)6,des-Gly-NH210]-Luteinizing Hormone-Releasing Hormone Ethylamide in Normal Women

1 reference

12 December 2020

Puberty without gonadotropins. A unique mechanism of sexual development

1 reference

12 December 2020

Combined treatment with LHRH agonist and pure antiandrogen in advanced carcinoma of prostate

1 reference

12 December 2020

Reversible induction of azoospermia in rhesus monkeys by constant infusion of a gonadotropin-releasing hormone agonist using osmotic minipumps

1 reference

12 December 2020

Heterogeneity of sperm density profiles following 16-week therapy with continuous infusion of high-dose LHRH analog plus testosterone

1 reference

12 December 2020

10.2165/00003495-198835010-00004

Identifiers

DOI

1 reference

PubMed ID

3278879

Dimensions Publication ID

13 September 2017

0 references

1 reference

PubMed ID

3278879